| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |